George Tesmol G, Endeshaw Molla M, Morgan Rachel E, Mahasenan Kiran V, Delfín Dawn A, Mukherjee Mitali S, Yakovich Adam J, Fotie Jean, Li Chenglong, Werbovetz Karl A
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, USA.
Bioorg Med Chem. 2007 Sep 15;15(18):6071-9. doi: 10.1016/j.bmc.2007.06.042. Epub 2007 Jun 27.
Dinitroanilines are of interest as antiprotozoal lead compounds because of their selective activity against the tubulin of these organisms, but concern has been raised due to the potentially mutagenic nitro groups. Analogues of N(1)-phenyl-3,5-dinitro-N(4),N(4)-di-n-butylsulfanilamide (GB-II-150, compound 2b), a selective antimitotic agent against African trypanosomes and Leishmania, have been prepared where the nitro groups are replaced with amino, chloro, cyano, carboxylate, methyl ester, amide, and methyl ketone moieties. Dicyano compound 5 displays IC(50) values that are comparable to 2b against purified leishmanial tubulin assembly (6.6 vs 7.4 microM), Trypanosoma brucei brucei growth in vitro (0.26 vs 0.18 microM), Leishmania donovani axenic amastigote growth in vitro (4.4 vs 2.3 microM), and in vitro toxicity against Vero cells (16 vs 9.7 microM). Computational studies provide a rationale for the antiparasitic order of activity of these analogues and further insight into the role of the substituents at the 3 and 5 positions of the sulfanilamide ring.
二硝基苯胺作为抗原生动物先导化合物备受关注,因为它们对这些生物体的微管蛋白具有选择性活性,但由于潜在的诱变硝基,人们对此表示担忧。已制备了N(1)-苯基-3,5-二硝基-N(4),N(4)-二正丁基磺胺(GB-II-150,化合物2b)的类似物,它是一种针对非洲锥虫和利什曼原虫的选择性抗有丝分裂剂,其中硝基被氨基、氯、氰基、羧酸盐、甲酯、酰胺和甲基酮部分取代。二氰基化合物5对纯化的利什曼原虫微管蛋白组装(6.6对7.4 microM)、布氏锥虫体外生长(0.26对0.18 microM)、杜氏利什曼原虫无菌无鞭毛体体外生长(4.4对2.3 microM)以及对Vero细胞的体外毒性(16对9.7 microM)显示出与2b相当的IC(50)值。计算研究为这些类似物的抗寄生虫活性顺序提供了理论依据,并进一步深入了解了磺胺环3位和5位取代基的作用。